ArticleFrontiers in pharmacology2022

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial.

Hui Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.